Levels of GSK3β and pGSK3β Y216 in the tumors tended to be associated with advanced tumor stages (III and IV), although this did not reach statistical significance ( P = 0.22; Table 1 ).
← all excerpts
Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
1
0.2200
0.2200